ECOAT and GENOCHEM winners of the 2012 National Competition to Create Innovative Technology Companies.

- Projects news

ECOAT and GENOCHEM winners of the 2012 National Competition to Create Innovative Technology Companies.

CREATION-DEVELOPMENT Category: ECOAT, founded by Olivier CHOULET, is developing polymers of vegetable origin for high-performance organic paint. ECOAT is developing pioneering alkyd resin technology for high-performance organic paint. This technology is based on:

  • A patent for cross-linking which lets paint dry without a heavy metal catalyst, with unmatched hardness and increased longevity
  • A search for new raw materials resulting in polymers with 100% vegetable structures

Research is being carried out jointly with ECOAT for polymers, the University of Nice for cross-linking and the University Claude Bernard Lyon 1 for raw materials from a vegetable source.

EMERGING BUSINESSES category: Founded by Cédric POINSARD, GENOCHEM produces innovative molecules with an application in the development of new drugs. Genochem is generating a catalog of entirely new synthetic intermediates and devising chemical structures that have never been prepared or put on sale before. Genochem will thus gain precious time for its customers' medicinal chemistry teams and increase the importance of molecules synthesized with therapeutic applications in mind by offering new molecules that are ready for use and available immediately. Synthetic intermediates have physicochemical properties that are compatible with the properties of drugs.

In addition, Genochem is a service provider: custom synthesis and Full-time equivalent, drawing on its experience in organic chemistry and API discovery projects.

Lastly Genochem is committed to working with academic research teams to develop new drugs. Genochem contributes medicinal chemistry expertise and preclinical profiling experience. Associated Laboratories: ICN Laboratory (Institute of Chemistry of Nice) CNRS-UNS C3M Laboratory (Mediterranean Center for Molecular Medicine) INSERM-UNS